| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 49 | 2019 | 470 | 6.090 |
Why?
|
| Oxidative Stress | 31 | 2012 | 447 | 2.730 |
Why?
|
| Genome | 11 | 2021 | 372 | 2.450 |
Why?
|
| Biological Evolution | 15 | 2023 | 919 | 2.370 |
Why?
|
| Lemur | 5 | 2021 | 12 | 2.200 |
Why?
|
| Evolution, Molecular | 19 | 2021 | 813 | 2.160 |
Why?
|
| Primates | 6 | 2020 | 151 | 1.980 |
Why?
|
| Genome, Human | 13 | 2021 | 756 | 1.950 |
Why?
|
| Aging | 11 | 2016 | 691 | 1.740 |
Why?
|
| Gene Dosage | 10 | 2012 | 207 | 1.620 |
Why?
|
| tau Proteins | 16 | 2019 | 62 | 1.600 |
Why?
|
| Pan troglodytes | 8 | 2014 | 197 | 1.440 |
Why?
|
| Genetics, Population | 8 | 2021 | 394 | 1.380 |
Why?
|
| Amyloid beta-Peptides | 20 | 2019 | 203 | 1.380 |
Why?
|
| Genetic Variation | 17 | 2017 | 1351 | 1.370 |
Why?
|
| Genomics | 7 | 2021 | 720 | 1.300 |
Why?
|
| Brain | 23 | 2021 | 2216 | 1.140 |
Why?
|
| Neurodegenerative Diseases | 6 | 2019 | 44 | 1.110 |
Why?
|
| Extinction, Biological | 5 | 2021 | 85 | 1.110 |
Why?
|
| Paleontology | 3 | 2015 | 81 | 1.100 |
Why?
|
| Adaptation, Physiological | 7 | 2023 | 306 | 1.100 |
Why?
|
| Hominidae | 4 | 2017 | 96 | 1.060 |
Why?
|
| Selection, Genetic | 6 | 2021 | 502 | 1.040 |
Why?
|
| Animals | 63 | 2021 | 26582 | 1.040 |
Why?
|
| Body Size | 2 | 2014 | 91 | 0.970 |
Why?
|
| Phylogeny | 12 | 2021 | 1137 | 0.860 |
Why?
|
| DNA | 7 | 2015 | 1294 | 0.840 |
Why?
|
| Oxidation-Reduction | 11 | 2013 | 373 | 0.810 |
Why?
|
| Humans | 107 | 2023 | 86645 | 0.800 |
Why?
|
| Anthropology, Physical | 1 | 2021 | 14 | 0.800 |
Why?
|
| Tauopathies | 2 | 2019 | 9 | 0.780 |
Why?
|
| Neurons | 17 | 2012 | 1546 | 0.780 |
Why?
|
| Strepsirhini | 2 | 2017 | 6 | 0.770 |
Why?
|
| Urban Renewal | 1 | 2020 | 2 | 0.750 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2019 | 86 | 0.730 |
Why?
|
| Genetic Markers | 3 | 2017 | 476 | 0.730 |
Why?
|
| Neurofibrillary Tangles | 13 | 2014 | 45 | 0.720 |
Why?
|
| Species Specificity | 11 | 2020 | 678 | 0.630 |
Why?
|
| Sequence Analysis, DNA | 10 | 2017 | 853 | 0.630 |
Why?
|
| Plaque, Amyloid | 9 | 2014 | 56 | 0.630 |
Why?
|
| Echolocation | 1 | 2017 | 6 | 0.620 |
Why?
|
| Color Vision | 3 | 2017 | 15 | 0.620 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2017 | 8 | 0.620 |
Why?
|
| Microsatellite Repeats | 1 | 2017 | 145 | 0.600 |
Why?
|
| Boxing | 1 | 2017 | 1 | 0.600 |
Why?
|
| Prion Diseases | 3 | 2010 | 32 | 0.600 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 68 | 0.600 |
Why?
|
| Behavior, Animal | 1 | 2020 | 373 | 0.590 |
Why?
|
| RNA | 3 | 2012 | 560 | 0.580 |
Why?
|
| Rod Opsins | 4 | 2017 | 9 | 0.580 |
Why?
|
| Iron | 6 | 2013 | 164 | 0.540 |
Why?
|
| DNA, Mitochondrial | 3 | 2017 | 183 | 0.540 |
Why?
|
| Dementia | 2 | 2017 | 187 | 0.530 |
Why?
|
| Lipid Peroxidation | 3 | 2011 | 44 | 0.530 |
Why?
|
| Base Sequence | 8 | 2021 | 2330 | 0.520 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 456 | 0.500 |
Why?
|
| Brain Injuries | 1 | 2017 | 161 | 0.490 |
Why?
|
| Apolipoprotein E4 | 2 | 2013 | 27 | 0.490 |
Why?
|
| Growth Disorders | 1 | 2014 | 63 | 0.490 |
Why?
|
| Pathology | 2 | 2011 | 30 | 0.480 |
Why?
|
| Cell Nucleus | 2 | 2021 | 579 | 0.470 |
Why?
|
| Aldehydes | 2 | 2011 | 17 | 0.470 |
Why?
|
| Plasmodium falciparum | 1 | 2013 | 47 | 0.470 |
Why?
|
| Darkness | 2 | 2017 | 49 | 0.450 |
Why?
|
| Madagascar | 6 | 2017 | 27 | 0.450 |
Why?
|
| Antioxidants | 5 | 2010 | 223 | 0.450 |
Why?
|
| Erythrocytes | 1 | 2013 | 255 | 0.440 |
Why?
|
| Dementia, Vascular | 1 | 2012 | 7 | 0.420 |
Why?
|
| Histocytochemistry | 1 | 2012 | 130 | 0.420 |
Why?
|
| Feeding Behavior | 1 | 2015 | 324 | 0.420 |
Why?
|
| Models, Neurological | 2 | 2012 | 405 | 0.390 |
Why?
|
| DNA Damage | 1 | 2012 | 366 | 0.380 |
Why?
|
| Nerve Degeneration | 4 | 2009 | 83 | 0.380 |
Why?
|
| DNA Repair | 1 | 2012 | 356 | 0.380 |
Why?
|
| Hippocampus | 8 | 2014 | 442 | 0.370 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 3030 | 0.370 |
Why?
|
| Sequence Analysis, RNA | 1 | 2011 | 217 | 0.370 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2009 | 9 | 0.360 |
Why?
|
| Diet | 5 | 2023 | 443 | 0.360 |
Why?
|
| Parkinson Disease | 5 | 2011 | 132 | 0.360 |
Why?
|
| Mitochondria | 5 | 2015 | 535 | 0.360 |
Why?
|
| Forests | 4 | 2021 | 20 | 0.350 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 371 | 0.350 |
Why?
|
| Feces | 1 | 2010 | 319 | 0.340 |
Why?
|
| Models, Genetic | 5 | 2017 | 926 | 0.340 |
Why?
|
| Body Height | 1 | 2009 | 99 | 0.330 |
Why?
|
| Tandem Repeat Sequences | 1 | 2008 | 26 | 0.320 |
Why?
|
| alpha-Amylases | 1 | 2007 | 2 | 0.310 |
Why?
|
| Disaster Planning | 2 | 2008 | 24 | 0.310 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2017 | 2357 | 0.310 |
Why?
|
| Transcriptome | 1 | 2011 | 580 | 0.300 |
Why?
|
| Immunohistochemistry | 13 | 2019 | 1753 | 0.300 |
Why?
|
| Phenotype | 7 | 2015 | 2378 | 0.300 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 22 | 0.300 |
Why?
|
| Fossils | 3 | 2015 | 337 | 0.300 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 303 | 0.290 |
Why?
|
| Aged, 80 and over | 18 | 2019 | 6509 | 0.290 |
Why?
|
| Independent Living | 1 | 2016 | 18 | 0.280 |
Why?
|
| Sequence Alignment | 4 | 2015 | 351 | 0.280 |
Why?
|
| Copper | 2 | 2004 | 71 | 0.280 |
Why?
|
| Neanderthals | 2 | 2017 | 15 | 0.280 |
Why?
|
| PAX9 Transcription Factor | 1 | 2005 | 2 | 0.280 |
Why?
|
| MSX1 Transcription Factor | 1 | 2005 | 3 | 0.280 |
Why?
|
| Color Perception | 1 | 2007 | 117 | 0.270 |
Why?
|
| Nerve Tissue Proteins | 5 | 2012 | 503 | 0.270 |
Why?
|
| Gene Deletion | 1 | 2007 | 329 | 0.270 |
Why?
|
| Trust | 1 | 2016 | 95 | 0.270 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2016 | 54 | 0.260 |
Why?
|
| Endangered Species | 2 | 2017 | 23 | 0.260 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2017 | 45 | 0.260 |
Why?
|
| Social Environment | 1 | 2016 | 188 | 0.260 |
Why?
|
| Metals | 1 | 2005 | 90 | 0.260 |
Why?
|
| Community Health Services | 1 | 2016 | 80 | 0.250 |
Why?
|
| Influenza, Human | 2 | 2008 | 329 | 0.250 |
Why?
|
| Social Support | 1 | 2016 | 193 | 0.250 |
Why?
|
| Lewy Body Disease | 3 | 2010 | 8 | 0.250 |
Why?
|
| Aged | 23 | 2019 | 18415 | 0.240 |
Why?
|
| Microtubules | 2 | 2004 | 119 | 0.230 |
Why?
|
| Olfactory Mucosa | 1 | 2003 | 33 | 0.230 |
Why?
|
| beta-Defensins | 2 | 2013 | 12 | 0.230 |
Why?
|
| History, 21st Century | 3 | 2012 | 175 | 0.220 |
Why?
|
| Reactive Oxygen Species | 5 | 2012 | 480 | 0.220 |
Why?
|
| History, 20th Century | 3 | 2012 | 312 | 0.210 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2013 | 689 | 0.210 |
Why?
|
| Geography | 2 | 2013 | 223 | 0.200 |
Why?
|
| Guanosine | 3 | 2009 | 29 | 0.200 |
Why?
|
| Middle Aged | 21 | 2019 | 25028 | 0.200 |
Why?
|
| Biomarkers | 4 | 2014 | 1718 | 0.200 |
Why?
|
| Poverty | 2 | 2016 | 173 | 0.200 |
Why?
|
| Cebus | 1 | 2021 | 17 | 0.200 |
Why?
|
| Publications | 1 | 2021 | 27 | 0.190 |
Why?
|
| Longevity | 1 | 2021 | 51 | 0.190 |
Why?
|
| Macaca mulatta | 3 | 2014 | 459 | 0.190 |
Why?
|
| Male | 24 | 2019 | 40967 | 0.190 |
Why?
|
| Membrane Proteins | 3 | 2017 | 1196 | 0.190 |
Why?
|
| Disease Outbreaks | 2 | 2008 | 154 | 0.190 |
Why?
|
| Metagenomics | 1 | 2021 | 83 | 0.190 |
Why?
|
| Adaptation, Biological | 1 | 2021 | 85 | 0.190 |
Why?
|
| Brain Chemistry | 4 | 2008 | 121 | 0.180 |
Why?
|
| Horses | 1 | 2019 | 35 | 0.180 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 1920 | 0.170 |
Why?
|
| Forensic Pathology | 1 | 2019 | 3 | 0.170 |
Why?
|
| Pyramidal Cells | 3 | 2011 | 80 | 0.170 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 157 | 0.170 |
Why?
|
| Chronic Traumatic Encephalopathy | 1 | 2019 | 2 | 0.170 |
Why?
|
| Symbiosis | 1 | 2020 | 118 | 0.170 |
Why?
|
| Post-Concussion Syndrome | 1 | 2019 | 7 | 0.170 |
Why?
|
| Haplotypes | 1 | 2021 | 642 | 0.170 |
Why?
|
| Microscopy, Electron | 2 | 2013 | 503 | 0.170 |
Why?
|
| Ecosystem | 2 | 2020 | 316 | 0.160 |
Why?
|
| Polymorphism, Genetic | 3 | 2017 | 819 | 0.160 |
Why?
|
| Prions | 2 | 2010 | 54 | 0.160 |
Why?
|
| Brain Concussion | 1 | 2019 | 59 | 0.160 |
Why?
|
| Liver | 2 | 2014 | 1230 | 0.160 |
Why?
|
| Dolphins | 1 | 2017 | 3 | 0.150 |
Why?
|
| Tarsiidae | 1 | 2017 | 1 | 0.150 |
Why?
|
| Military Personnel | 1 | 2019 | 85 | 0.150 |
Why?
|
| Sympatry | 1 | 2017 | 9 | 0.150 |
Why?
|
| Lemuridae | 1 | 2017 | 5 | 0.150 |
Why?
|
| HIV Infections | 1 | 2016 | 772 | 0.150 |
Why?
|
| Metabolomics | 2 | 2014 | 68 | 0.150 |
Why?
|
| Chitin | 2 | 2007 | 10 | 0.150 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 26 | 0.150 |
Why?
|
| Choroid Plexus | 2 | 2013 | 14 | 0.150 |
Why?
|
| Social Justice | 1 | 2007 | 49 | 0.150 |
Why?
|
| Phosphorylation | 4 | 2012 | 1106 | 0.150 |
Why?
|
| DNA Primers | 2 | 2008 | 543 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 266 | 0.140 |
Why?
|
| DNA Transposable Elements | 1 | 2017 | 169 | 0.140 |
Why?
|
| Brain Stem | 2 | 2011 | 165 | 0.140 |
Why?
|
| Seed Dispersal | 1 | 2016 | 1 | 0.140 |
Why?
|
| Baltimore | 2 | 2016 | 36 | 0.140 |
Why?
|
| Amyloid | 2 | 2009 | 85 | 0.140 |
Why?
|
| Chiroptera | 1 | 2017 | 51 | 0.140 |
Why?
|
| Opsins | 1 | 2016 | 10 | 0.140 |
Why?
|
| Female | 21 | 2019 | 44534 | 0.140 |
Why?
|
| Trees | 1 | 2016 | 30 | 0.140 |
Why?
|
| Referral and Consultation | 1 | 2019 | 328 | 0.140 |
Why?
|
| Mammoths | 1 | 2015 | 1 | 0.140 |
Why?
|
| Genetic Speciation | 1 | 2017 | 113 | 0.130 |
Why?
|
| Brain Injury, Chronic | 1 | 2015 | 9 | 0.130 |
Why?
|
| Amino Acid Sequence | 3 | 2015 | 2062 | 0.130 |
Why?
|
| Disease Progression | 3 | 2017 | 1531 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2017 | 217 | 0.130 |
Why?
|
| Duffy Blood-Group System | 1 | 2014 | 7 | 0.130 |
Why?
|
| Myosin Heavy Chains | 1 | 2015 | 88 | 0.130 |
Why?
|
| Uganda | 1 | 2014 | 34 | 0.130 |
Why?
|
| Residence Characteristics | 2 | 2016 | 197 | 0.120 |
Why?
|
| Apolipoprotein E3 | 1 | 2013 | 7 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 79 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 115 | 0.120 |
Why?
|
| Agriculture | 1 | 2014 | 38 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2008 | 371 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 171 | 0.120 |
Why?
|
| Time Factors | 3 | 2017 | 5210 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 212 | 0.110 |
Why?
|
| Amyloidosis | 2 | 2012 | 115 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 286 | 0.110 |
Why?
|
| Platyrrhini | 1 | 2012 | 2 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 162 | 0.110 |
Why?
|
| DNA, Intergenic | 1 | 2012 | 25 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2011 | 1805 | 0.110 |
Why?
|
| Pseudogenes | 1 | 2012 | 35 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2008 | 245 | 0.110 |
Why?
|
| Systems Biology | 1 | 2012 | 42 | 0.110 |
Why?
|
| Gene Frequency | 1 | 2014 | 677 | 0.110 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2012 | 13 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2016 | 575 | 0.110 |
Why?
|
| Genotype | 3 | 2013 | 1851 | 0.110 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 63 | 0.110 |
Why?
|
| Lipofuscin | 1 | 2011 | 2 | 0.100 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2011 | 29 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2012 | 285 | 0.100 |
Why?
|
| Ribosomal Protein S6 | 1 | 2011 | 4 | 0.100 |
Why?
|
| Neurobiology | 1 | 2011 | 10 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 296 | 0.100 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2011 | 12 | 0.100 |
Why?
|
| Open Reading Frames | 1 | 2011 | 117 | 0.100 |
Why?
|
| Cytoplasmic Granules | 1 | 2011 | 94 | 0.100 |
Why?
|
| Nucleotides | 1 | 2011 | 95 | 0.100 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 66 | 0.100 |
Why?
|
| Adult | 10 | 2019 | 25648 | 0.100 |
Why?
|
| GTP Phosphohydrolases | 1 | 2011 | 71 | 0.100 |
Why?
|
| Dogs | 1 | 2011 | 685 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2818 | 0.100 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2010 | 27 | 0.100 |
Why?
|
| Internet | 1 | 2013 | 312 | 0.090 |
Why?
|
| Energy Metabolism | 1 | 2012 | 271 | 0.090 |
Why?
|
| CD3 Complex | 1 | 2010 | 135 | 0.090 |
Why?
|
| Cerebral Cortex | 2 | 2012 | 584 | 0.090 |
Why?
|
| Amino Acid Substitution | 2 | 2015 | 339 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 123 | 0.090 |
Why?
|
| Paraffin Embedding | 1 | 2010 | 78 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 100 | 0.090 |
Why?
|
| Exercise | 1 | 2013 | 315 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 176 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2009 | 502 | 0.090 |
Why?
|
| Kynurenine | 1 | 2010 | 20 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 927 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2010 | 268 | 0.090 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 54 | 0.090 |
Why?
|
| Caloric Restriction | 1 | 2009 | 14 | 0.090 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2009 | 4 | 0.090 |
Why?
|
| DNA Mutational Analysis | 2 | 2010 | 526 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2010 | 673 | 0.090 |
Why?
|
| S Phase | 1 | 2009 | 62 | 0.090 |
Why?
|
| Growth | 1 | 2009 | 43 | 0.090 |
Why?
|
| Brain Neoplasms | 2 | 2006 | 763 | 0.090 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2009 | 48 | 0.080 |
Why?
|
| Genes, myc | 1 | 2009 | 39 | 0.080 |
Why?
|
| Neocortex | 3 | 2006 | 95 | 0.080 |
Why?
|
| Hypoxia, Brain | 1 | 2009 | 41 | 0.080 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 39 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 66 | 0.080 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 2008 | 1 | 0.080 |
Why?
|
| Ceruloplasmin | 1 | 2008 | 9 | 0.080 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2009 | 143 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 2009 | 177 | 0.080 |
Why?
|
| Starch | 1 | 2007 | 8 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 348 | 0.080 |
Why?
|
| United States | 3 | 2019 | 6674 | 0.080 |
Why?
|
| Polysaccharides | 1 | 2007 | 89 | 0.080 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2007 | 3 | 0.080 |
Why?
|
| Genomic Imprinting | 1 | 2007 | 33 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2011 | 376 | 0.070 |
Why?
|
| Pan paniscus | 1 | 2007 | 10 | 0.070 |
Why?
|
| Antigens | 1 | 2008 | 228 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 930 | 0.070 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Gorilla gorilla | 1 | 2007 | 41 | 0.070 |
Why?
|
| Synapses | 1 | 2009 | 265 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1621 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2007 | 93 | 0.070 |
Why?
|
| Family | 1 | 2008 | 311 | 0.070 |
Why?
|
| Antibodies | 1 | 2008 | 350 | 0.070 |
Why?
|
| Geographic Information Systems | 1 | 2016 | 20 | 0.070 |
Why?
|
| Social Isolation | 1 | 2016 | 67 | 0.070 |
Why?
|
| Needle-Exchange Programs | 1 | 2016 | 18 | 0.070 |
Why?
|
| Health Priorities | 1 | 2016 | 23 | 0.070 |
Why?
|
| Urban Health | 1 | 2016 | 55 | 0.070 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2005 | 25 | 0.070 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 388 | 0.070 |
Why?
|
| Glycation End Products, Advanced | 1 | 2005 | 13 | 0.070 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 86 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 204 | 0.070 |
Why?
|
| Interviews as Topic | 1 | 2016 | 319 | 0.070 |
Why?
|
| Adolescent | 3 | 2014 | 8982 | 0.070 |
Why?
|
| Likelihood Functions | 1 | 2005 | 251 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2006 | 278 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 1169 | 0.060 |
Why?
|
| Young Adult | 5 | 2019 | 5976 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 2232 | 0.060 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2004 | 8 | 0.060 |
Why?
|
| Urban Population | 1 | 2016 | 213 | 0.060 |
Why?
|
| Lysine | 1 | 2005 | 147 | 0.060 |
Why?
|
| Mice | 4 | 2011 | 11352 | 0.060 |
Why?
|
| Cyclin B | 1 | 2004 | 17 | 0.060 |
Why?
|
| Glioma | 1 | 2006 | 285 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2004 | 94 | 0.060 |
Why?
|
| Cyclins | 1 | 2004 | 82 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 439 | 0.060 |
Why?
|
| Autopsy | 2 | 2019 | 116 | 0.060 |
Why?
|
| Heme Oxygenase-1 | 1 | 2003 | 19 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2016 | 839 | 0.060 |
Why?
|
| Rainforest | 1 | 2023 | 8 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2003 | 44 | 0.060 |
Why?
|
| Hydroxyl Radical | 1 | 2003 | 35 | 0.060 |
Why?
|
| Electron Transport Complex IV | 1 | 2003 | 47 | 0.060 |
Why?
|
| Acclimatization | 1 | 2023 | 76 | 0.060 |
Why?
|
| Multiple System Atrophy | 1 | 2002 | 4 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 394 | 0.050 |
Why?
|
| Deoxyguanosine | 1 | 2002 | 28 | 0.050 |
Why?
|
| Hydrocephalus | 1 | 2003 | 101 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2008 | 2271 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2016 | 428 | 0.050 |
Why?
|
| Herbivory | 1 | 2021 | 25 | 0.050 |
Why?
|
| RNA, Ribosomal | 2 | 2011 | 60 | 0.050 |
Why?
|
| Computer Simulation | 2 | 2016 | 1078 | 0.050 |
Why?
|
| Amino Acids | 1 | 2021 | 252 | 0.050 |
Why?
|
| Asthma | 1 | 2008 | 955 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2011 | 78 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 879 | 0.040 |
Why?
|
| Biopsy | 1 | 2003 | 1163 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2010 | 45 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2006 | 1074 | 0.040 |
Why?
|
| Astrocytes | 2 | 2012 | 139 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2021 | 679 | 0.040 |
Why?
|
| Veterans Health | 1 | 2019 | 15 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2011 | 782 | 0.040 |
Why?
|
| Risk Factors | 2 | 2016 | 5417 | 0.040 |
Why?
|
| Social Responsibility | 1 | 2008 | 57 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2008 | 76 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2013 | 712 | 0.040 |
Why?
|
| Callithrix | 1 | 2017 | 12 | 0.040 |
Why?
|
| Borneo | 1 | 2017 | 1 | 0.040 |
Why?
|
| Bibliometrics | 1 | 2007 | 37 | 0.040 |
Why?
|
| Policy Making | 1 | 2007 | 62 | 0.040 |
Why?
|
| Cell Line | 2 | 2012 | 2468 | 0.040 |
Why?
|
| Phylogeography | 1 | 2017 | 41 | 0.040 |
Why?
|
| Cytoplasm | 2 | 2009 | 281 | 0.040 |
Why?
|
| Global Health | 1 | 2008 | 193 | 0.040 |
Why?
|
| Climate | 1 | 2017 | 50 | 0.040 |
Why?
|
| Cell Death | 2 | 2008 | 256 | 0.040 |
Why?
|
| Gene Expression | 2 | 2014 | 1284 | 0.040 |
Why?
|
| Opossums | 1 | 2016 | 4 | 0.040 |
Why?
|
| Arctic Regions | 1 | 2015 | 5 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2015 | 17 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2015 | 15 | 0.030 |
Why?
|
| Elephants | 1 | 2015 | 16 | 0.030 |
Why?
|
| Environment | 1 | 2017 | 219 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2019 | 371 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 67 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 1384 | 0.030 |
Why?
|
| Africa, Southern | 1 | 2014 | 1 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2016 | 193 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 21 | 0.030 |
Why?
|
| Genetic Drift | 1 | 2014 | 37 | 0.030 |
Why?
|
| Demography | 1 | 2014 | 177 | 0.030 |
Why?
|
| Africa, Central | 1 | 2014 | 4 | 0.030 |
Why?
|
| Africa, Western | 1 | 2014 | 10 | 0.030 |
Why?
|
| Cooking | 1 | 2014 | 55 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2013 | 90 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 736 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 615 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2009 | 696 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 425 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 151 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 2012 | 52 | 0.030 |
Why?
|
| Chemotaxis | 1 | 2012 | 72 | 0.030 |
Why?
|
| Organ Size | 1 | 2012 | 364 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2011 | 58 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 29 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2011 | 44 | 0.030 |
Why?
|
| Microglia | 1 | 2012 | 102 | 0.030 |
Why?
|
| Adenosine Diphosphate | 1 | 2011 | 55 | 0.030 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2011 | 20 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 154 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2262 | 0.020 |
Why?
|
| Lewy Bodies | 1 | 2010 | 1 | 0.020 |
Why?
|
| alpha-Synuclein | 1 | 2010 | 13 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 2010 | 34 | 0.020 |
Why?
|
| Dynamins | 1 | 2011 | 49 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 164 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 316 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 172 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2010 | 40 | 0.020 |
Why?
|
| Culture | 1 | 2010 | 53 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2010 | 52 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 314 | 0.020 |
Why?
|
| Child | 2 | 2014 | 6928 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 369 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 242 | 0.020 |
Why?
|
| Wound Healing | 1 | 2012 | 344 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 439 | 0.020 |
Why?
|
| Minichromosome Maintenance Complex Component 2 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Autophagy | 1 | 2011 | 149 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 896 | 0.020 |
Why?
|
| Maze Learning | 1 | 2009 | 28 | 0.020 |
Why?
|
| Presenilins | 1 | 2008 | 6 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 969 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2012 | 425 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2012 | 409 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 2008 | 27 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2008 | 17 | 0.020 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2008 | 2 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 2379 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 776 | 0.020 |
Why?
|
| Heparitin Sulfate | 1 | 2007 | 27 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2008 | 87 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 411 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 3047 | 0.020 |
Why?
|
| Sp Transcription Factors | 1 | 2007 | 1 | 0.020 |
Why?
|
| Extraembryonic Membranes | 1 | 2007 | 8 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2007 | 102 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 25 | 0.020 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2007 | 6 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 3613 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2006 | 16 | 0.020 |
Why?
|
| Euchromatin | 1 | 2006 | 6 | 0.020 |
Why?
|
| Achilles Tendon | 1 | 2007 | 15 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2008 | 125 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2006 | 63 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2007 | 55 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2009 | 236 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2009 | 460 | 0.020 |
Why?
|
| Hormones | 1 | 2007 | 141 | 0.020 |
Why?
|
| CpG Islands | 1 | 2007 | 151 | 0.020 |
Why?
|
| Huntingtin Protein | 1 | 2006 | 10 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2006 | 216 | 0.020 |
Why?
|
| Vitamin E | 1 | 2006 | 35 | 0.020 |
Why?
|
| Huntington Disease | 1 | 2006 | 37 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2006 | 69 | 0.020 |
Why?
|
| Neuroglia | 1 | 2006 | 104 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2010 | 535 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2006 | 125 | 0.020 |
Why?
|
| Vaccination | 1 | 2008 | 254 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2007 | 293 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 446 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1578 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2007 | 147 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2007 | 196 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 243 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 94 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2006 | 98 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 232 | 0.020 |
Why?
|
| Apoptosis | 1 | 2012 | 1683 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2005 | 66 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 473 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 1204 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 1540 | 0.020 |
Why?
|
| Histones | 1 | 2007 | 311 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 3990 | 0.020 |
Why?
|
| Research Design | 1 | 2008 | 594 | 0.020 |
Why?
|
| Cyclin B1 | 1 | 2004 | 17 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 43 | 0.020 |
Why?
|
| G2 Phase | 1 | 2004 | 34 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 576 | 0.020 |
Why?
|
| Cytosol | 1 | 2004 | 189 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 74 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 378 | 0.010 |
Why?
|
| Software | 1 | 2008 | 654 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 153 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1749 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 623 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 674 | 0.010 |
Why?
|
| Inflammation | 1 | 2008 | 920 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2007 | 628 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 1376 | 0.010 |
Why?
|
| Proteins | 1 | 2007 | 777 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 1981 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 376 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2705 | 0.010 |
Why?
|
| Algorithms | 1 | 2006 | 1830 | 0.010 |
Why?
|
| Mutation | 1 | 2005 | 3968 | 0.010 |
Why?
|